Direct‐to‐Biology: Streamlining the Path From Chemistry to Biology in Drug Discovery
Authors:
Top Cited Papers
Open Access
- 20 February 2026
- journal article
- review article
- Published by Wiley in ChemMedChem
- Vol. 21 (4) , e202501080
Abstract
Direct‐to‐biology (D2B) has emerged as a transformative concept in early drug discovery, defined by the direct on‐target screening of crude reaction mixtures without prior purification. First coined in 2021, the approach builds on advances in nanoscale synthesis platforms and was shaped by seminal studies that demonstrated the feasibility of plate‐based microscale chemistry for library generation. Today, D2B is increasingly adopted in academia and industry, with campaigns exploring diverse reaction classes, targeting modalities, and assay platforms. Thus, very recently, the first commercial providers now offer D2B services for ligand optimization, further driving adoption. Yet, despite clear advantages in speed, cost, and sustainability, D2B also faces limitations from assay interference and technical constraints in reaction miniaturization. Looking ahead, integration with AI‐driven design and high‐content biology promises to expand the scope of D2B and position it as a robust complement to traditional discovery paradigms.Keywords
This publication has 94 references indexed in Scilit:
- Chemistry: Chemical con artists foil drug discoveryNature, 2014
- Efficient discovery of bioactive scaffolds by activity-directed synthesisNature Chemistry, 2014
- Modern multicomponent reactions for better drug synthesesOrganic Chemistry Frontiers, 2014
- Late‐Stage Functionalization of Biologically Active Heterocycles Through Photoredox CatalysisAngewandte Chemie International Edition, 2014
- Off-Rate Screening (ORS) By Surface Plasmon Resonance. An Efficient Method to Kinetically Sample Hit to Lead Chemical Space from Unpurified Reaction ProductsJournal of Medicinal Chemistry, 2014
- Metal Impurities Cause False Positives in High-Throughput Screening CampaignsACS Medicinal Chemistry Letters, 2012
- Discovery of an α-Amino C–H Arylation Reaction Using the Strategy of Accelerated SerendipityScience, 2011
- The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug CandidatesJournal of Medicinal Chemistry, 2011
- Epigenetic modifications as therapeutic targetsNature Biotechnology, 2010
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activatorsNature Reviews Drug Discovery, 2008